FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer

Clinical trial NCT05999396 · RECRUITING

Trial details

NCT number: NCT05999396
Sponsor: German Cancer Research Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Breast Carcinoma Sarcoma Penile Carcinoma

Start date: 2024-01-12
Primary completion: 2026-10-30
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.